Company
United StatesPublic company, NASDAQ: LINLinde Inc. (NASDAQ: LIN), Magna, UT – FDA Inspections
Inspection records and compliance data for Linde Inc. in Magna, Utah. 3 FDA inspections on record, last inspected August 28, 2024. Publicly traded as NASDAQ: LIN.
Company Profile
This profile covers Linde Inc. based in Magna, Utah, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Unclassified
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected November 4, 2013. Last inspected August 28, 2024.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| August 28, 2024 | Not classified | Foods & Cosmetics | 1247776 |
| April 11, 2024 | Not classified | Animal Drugs & Feeds | 1235909 |
| November 4, 2013 | NAI | Human Drugs · Drug Quality Assurance | 854351 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Linde Inc.
Stock ticker
LIN
Exchange
NASDAQ
Share price
$522.49
Market cap
$239.9B
Price as of
November 13, 2026
FEI Number
1750014
Address
12385 West Sr 201, Magna, Utah 84044, United States
Country
United States
ID: e64056fb-0048-44b5-a8c3-7b05a57ed4d9